Inventor

REEL JON K

US37 patents

⚠️ This page may combine multiple inventors who share the name “REEL JON K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

REEL JON K

LILLY CO ELI

Chemical compounds as inhibitors of amyloid beta protein production

Angiotensin II antagonists

Inhibitors of amyloid beta-protein production

Angiotensin ii antagonist 1,3-imidazoles and use thereas

Treatment of alzheimer&#39;s disease employing inhibitors of cathepsin D

Benzylidene rhodanines

Angiotensin II antagonists

Angiotensin II antagonists

Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis

Heterocyclic compounds and their use

Heterocyclic compounds

Angiotensin II antagonists

Angiotensin II antagonists

Angiotensin II antagonists

Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof

Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Heterocyclic compounds

ATHENA NEUROSCIENCES INC

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting alpha- amyloid peptide release and/or its synthesis by use of such compounds

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use

ELAN PHARM INC

Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis

Compounds for inhibiting β-amyloid peptide release and/or its synthesis

Compounds for inhibiting β-amyloid peptide release and/or its synthesis

Compounds for inhibiting β-amyloid peptide release and/or its synthesis

Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis

ELAN PHARMACEUTIALS INC

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Treatment of alzheimer's disease employing inhibitors of cathepsin D